Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2006

01.11.2006

Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees

verfasst von: Susan M. Moore, Melinda J. Wilkerson, Rolan D. Davis, Carol R. Wyatt, Deborah J. Briggs

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

 

A nonradioactive multi-parameter flow cytometry assay was developed to identify antigen-specific lymphocytes in human subjects previously vaccinated against rabies virus and was subsequently compared to the standard tritiated thymidine method. A cell tracking dye, carboxyfluorescein succinimidyl ester, was used in combination with surface label for CD4 and CD8 cells in order to determine the response of lymphocytes to killed rabies virus in an antigen recall assay. The rabies virus-specific lymphocyte response was compared to the humoral immune response in each of ten vaccinated and five non-vaccinated subjects. Lymphocyte responses to rabies virus were observed in all ten vaccinated subjects; some noted as early as 3 days after stimulation while others were not until 7 days after stimulation. There was good agreement between the proliferation index of the CFSE assay and the simulation index of the [3H]thymidine assay (kappa statistic=0.73). An inverse relationship was detected between the level of rabies virus neutralizing antibody (RVNA) and the lymphocyte response to inactivated rabies virus in the vaccinated subjects. The association between cytokines production and level of humoral and cellular response was investigated in four representative subjects. Two vaccinated subjects with high proliferation indices and low RVNA titers produced Th1 type cytokines to rabies virus stimulation, whereas two vaccinated individuals with low proliferation indices and high RVNA titers responses did not produce these cytokines.
Literatur
1.
Zurück zum Zitat Haupt W: Rabies–Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742–1749, 1999PubMedCrossRef Haupt W: Rabies–Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742–1749, 1999PubMedCrossRef
2.
Zurück zum Zitat Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145–155, 2001PubMed Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145–155, 2001PubMed
3.
Zurück zum Zitat Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163–182, 2002PubMed Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163–182, 2002PubMed
4.
Zurück zum Zitat Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160–168 Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160–168
5.
Zurück zum Zitat Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661–2667, 2000PubMedCrossRef Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661–2667, 2000PubMedCrossRef
6.
Zurück zum Zitat Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735–760, 1992PubMed Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735–760, 1992PubMed
7.
Zurück zum Zitat Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711–3719, 1998PubMed Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711–3719, 1998PubMed
8.
Zurück zum Zitat Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176–189, 1998PubMed Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176–189, 1998PubMed
9.
Zurück zum Zitat Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351–371 Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351–371
10.
Zurück zum Zitat Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88–92, 2005PubMedCrossRef Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88–92, 2005PubMedCrossRef
11.
Zurück zum Zitat Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287–292, 1994PubMedCrossRef Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287–292, 1994PubMedCrossRef
12.
Zurück zum Zitat Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224–230, 1991PubMedCrossRef Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224–230, 1991PubMedCrossRef
13.
Zurück zum Zitat Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559–564, 1999PubMedCrossRef Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559–564, 1999PubMedCrossRef
14.
Zurück zum Zitat Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99–112, 1999PubMedCrossRef Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99–112, 1999PubMedCrossRef
15.
Zurück zum Zitat Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541, 1973PubMed Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541, 1973PubMed
16.
Zurück zum Zitat Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373 Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373
17.
Zurück zum Zitat Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1–21. United States, Morbidity and Mortality Weekly Report, 1999 Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1–21. United States, Morbidity and Mortality Weekly Report, 1999
18.
Zurück zum Zitat World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992 World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992
19.
Zurück zum Zitat Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991 Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991
20.
Zurück zum Zitat Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419–430, 2003PubMedCrossRef Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419–430, 2003PubMedCrossRef
21.
Zurück zum Zitat Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507–510, 1992PubMedCrossRef Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507–510, 1992PubMedCrossRef
22.
Zurück zum Zitat Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183, 1997PubMedCrossRef Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183, 1997PubMedCrossRef
23.
Zurück zum Zitat Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199–207, 1998PubMedCrossRef Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199–207, 1998PubMedCrossRef
24.
Zurück zum Zitat Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156–165, 2006PubMedCrossRef Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156–165, 2006PubMedCrossRef
Metadaten
Titel
Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees
verfasst von
Susan M. Moore
Melinda J. Wilkerson
Rolan D. Davis
Carol R. Wyatt
Deborah J. Briggs
Publikationsdatum
01.11.2006
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2006
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9044-0

Weitere Artikel der Ausgabe 6/2006

Journal of Clinical Immunology 6/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.